Warberg Asset Management’s Oragenics OGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-333
Closed -$3.69K 215
2024
Q4
$3.69K Hold
333
﹤0.01% 179
2024
Q3
$3.86K Hold
333
﹤0.01% 182
2024
Q2
$10.4K Sell
333
-1,335
-80% -$60.4K ﹤0.01% 175
2024
Q1
$72K Buy
+1,668
New +$165K 0.01% 123

Other funds holding OGEN

Warberg Asset Management's OGEN Position: Q1 2025 in Review

Warberg Asset Management sold out of Oragenics (OGEN) in Q1 2025, closing a stake of 333 shares — an estimated $3.69K sold.

Warberg Asset Management first reported a position in OGEN in Q1 2024 and held it in 4 quarters. The position peaked at $72K in Q1 2024. 17 funds tracked by Wall St. Rank hold OGEN as of Q1 2025.

  • Warberg Asset Management reported no remaining Oragenics position as of Q1 2025 after selling out during the quarter.
  • Warberg Asset Management sold 333 Oragenics shares in Q1 2025, an estimated $3.69K.
  • Warberg Asset Management first reported a position in Oragenics in Q1 2024 and held it in 4 quarters.
  • Warberg Asset Management's Oragenics position peaked at $72K in Q1 2024.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q1 2025.

Based on Warberg Asset Management's 13F filing for Q1 2025, filed 9 May 2025.